Dianthus Therapeutics, Inc.
DNTH·252828108·US·Common Stock·Healthcare - Biotechnology-13D/G
DNTH (Dianthus Therapeutics, Inc.) is held by 140 institutional investors as of Q2 2026. Largest holders: FMR LLC ($799.3M), BlackRock, Inc. ($402M), WELLINGTON MANAGEMENT GROUP LLP ($314.8M). Net institutional sentiment: Bullish.
140
Holders
(12 Elite)
$3.9B
Total Value
70% (146)
Consensus
102 buying - 44 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Aug 19, 2026 · Activists Aug 14, 2026 · Congress none
InsiderRSRead SimonSell $327KAug 19, 2026
InsiderRSRead SimonExercise 3K shAug 19, 2026
ActivistSISirenia Capital Management LP3.1%Aug 14, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 150
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer